CD274 and non-small cell lung carcinoma: On a final note, high IL-2 circulating levels have been correlated with improved OS and response to PD-1/PD-L1 blockade in NSCLC demonstrating a potential for improved treatment outcomes in patient groups with higher risk of poor prognosis to anti-PD-1/PD-L1 inhibitors (130).